An investigation on behalf of investors in NASDAQ:CYTX shares over potential wrongdoing at Cytori Therapeutics was announced and NASDAQ:CYTX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/25/2014 -- An investigation on behalf of investors in Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Cytori Therapeutics Inc.
Investors who purchased shares of Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Cytori Therapeutics officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Cytori Therapeutics Inc. reported that its annual Total Revenue declined from $14.50 million in 2012 to $12.20 million in 2013 and that its Net loss declined from $32.28 million in 2012 to $26.18 million in 2013. Shares of Cytori Therapeutics Inc. (USA) (NASDAQ:CYTX) declined from $4.75 per share in September 2012 to as low as $1.38 per share on August 21, 2014.
Those who purchased shares of Cytori Therapeutics Inc. have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com